Amniotic tissue for bile duct repair in living donor liver transplant
This trial tests whether using amniotic tissue during bile duct connection surgery can improve outcomes for people receiving a liver transplant from a living donor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled to receive a liver transplant from a living donor.
- You are willing and able to give informed consent.
- You are not pregnant and not a vulnerable adult (e.g., cognitively impaired or under direct care of the investigator).
- You have been cleared for safety by the transplant selection committee.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at whether a liver transplant can help people who have liver cancer that has spread into the bile ducts, which are the tubes that carry bile from the liver. We want to see if this surgery is safe and how well it works for these patients.
This trial tests whether a living donor liver transplant can help people with a certain type of liver cancer (intrahepatic cholangiocarcinoma) that cannot be removed by surgery. It is for patients whose cancer has not spread and who have responded well to chemotherapy.
This study looks at living donor liver transplant care and follows patients for about 3 years to see how they do over time. If you had (or are scheduled for) a living donor liver transplant and can be followed long-term, this trial may be able to collect your outcomes.
This study tests whether a type of stem cell, given during liver transplant surgery, can help prevent bile duct complications. It is for people receiving a liver from a living donor.
This study compares two ways of connecting the bile duct during a liver transplant to see which leads to a smoother recovery. It is for adults having a planned first transplant from a deceased donor.
This trial looks at liver transplant for people with advanced intrahepatic cholangiocarcinoma (a bile duct cancer inside the liver) when the cancer is not safely removable and stays controlled. It may help some patients live longer and with better quality of life by replacing the diseased liver—if strict safety and disease-stability requirements are met.
Hear when a new Liver Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.